Pharmacovigilance and pediatrics people get together at EMA to better tackle safety concerns
This article was originally published in SRA
Executive Summary
A new joint working group comprising members of the European Medicines Agency's pharmacovigilance (PRAC) and pediatric committees (PDCO) has been created to exchange information and expertise on pediatric safety issues at both committees and to share experience or provide insights on the therapeutic context of issues under discussion.